Literature DB >> 26210223

The clinical importance of parathyroid atypia: is long-term surveillance necessary?

Kelly L McCoy1, Raja R Seethala2, Michaele J Armstrong3, Marina N Nikiforova2, Michael T Stang3, Sally E Carty3, Linwah Yip3.   

Abstract

BACKGROUND: The uncommon diagnosis of atypical parathyroid adenoma (APA) creates a clinical conundrum for surveillance. We evaluated a large series of APA to determine long-term outcomes.
METHODS: Prospectively collected data were retrieved for patients with a diagnosis of histologic APA defined by presence of ≥2 criteria: clinical/intraoperative adherence, fibrotic bands, trabecular growth, or mitotic rate of >1/10 per high-power field without indisputable signs of malignancy. Follow-up was at 2 weeks, 6 months, and yearly thereafter.
RESULTS: From 1970 to 2014, 51 patients (1.2%) with primary hyperparathyroidism had a diagnosed APA. Mean age was 56 years (range, 19-83), and 61% were women. Intraoperatively, 11 of 51 glands (22%) were adherent, requiring concurrent thyroid lobectomy. Common microscopic findings were fibrosis (78%), trabecular growth (37%), and increased mitotic count (24%); the mean APA weight was 3.14 g (range, 167 mg-38 g). Loss of heterozygosity occurred in 25 of 38 tested patients (66%) at the p21 locus in 9 cases, at CDC73 and PTEN in 6, and at RB1 in 4 cases, with mean fractional allelic loss of 24% (range, 6-79). With mean follow-up of 5 years (range, 0.5-18), no patient has developed recurrence.
CONCLUSION: Over a mean follow-up of 5 years, we observed no recurrences after APA resection. Molecular features had no discernable impact, indicating that long-term follow-up may be unnecessary.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26210223     DOI: 10.1016/j.surg.2015.06.022

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.

Authors:  E Sanpaolo; M Miroballo; S Corbetta; C Verdelli; F Baorda; T Balsamo; P Graziano; F P Fabrizio; L Cinque; A Scillitani; L A Muscarella; Vito Guarnieri
Journal:  Endocrine       Date:  2016-02-15       Impact factor: 3.633

2.  Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.

Authors:  Angelica M Silva-Figueroa; Roland Bassett; Ioannis Christakis; Pablo Moreno; Callisia N Clarke; Naifa L Busaidy; Elizabeth G Grubbs; Jeffrey E Lee; Nancy D Perrier; Michelle D Williams
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

3.  Retropharyngeal Parathyroid Glands: Important Differences.

Authors:  James W Gallagher; Meghan L Kelley; Linwah Yip; Sally E Carty; Kelly L McCoy
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

4.  The diagnostic and therapeutic challenges in the management of a double giant parathyroid adenoma.

Authors:  Arvind Krishnamurthy; Urmila Majhi; Gomadaam Kuppusamy Rangarajan; Vijayalakshmi Ramshankar; Ramachandran Krishna Kumar
Journal:  Indian J Nucl Med       Date:  2016 Oct-Dec

5.  Atypical parathyroid adenoma: clinical and anatomical pathologic features.

Authors:  Alessandro Galani; Riccardo Morandi; Mira Dimko; Sarah Molfino; Carla Baronchelli; Silvia Lai; Federico Gheza; Carlo Cappelli; Claudio Casella
Journal:  World J Surg Oncol       Date:  2021-01-20       Impact factor: 2.754

Review 6.  Genomics and Epigenomics in Parathyroid Neoplasia: from Bench to Surgical Pathology Practice.

Authors:  C Christofer Juhlin; Lori A Erickson
Journal:  Endocr Pathol       Date:  2020-12-02       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.